Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis

Publisher： Karger

E-ISSN： 1423-0313|88|3-4|213-224

ISSN： 0031-7012

Source： Pharmacology, Vol.88, Iss.3-4, 2011-10, pp. : 213-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunoproteome of Aspergillus fumigatus Using Sera of Patients with Invasive Aspergillosis

By Virginio Emylli D.   Kubitschek-Barreira Paula H.   Batista Marjorie Vieira   Schirmer Marcelo R.   Abdelhay Eliana   Shikanai-Yasuda Maria A.   Lopes-Bezerra Leila M.  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 14505-14530

MDPI

Access to resources Recommend Favorite

Cytotoxic Drug Safety Cabinets

By  

The Australian Journal of Hospital Pharmacy, Vol. 29, Iss. 5, 1999-10 ,pp. : 291-291

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

By Adamska Aleksandra   Domenichini Alice   Falasca Marco  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1338-1338

MDPI

Access to resources Recommend Favorite

Comparative Study on the Efficacy of Liposomal Amphotericin B and Voriconazole in a Murine Pulmonary Aspergillosis Model

By  

Chemotherapy, Vol. 55, Iss. 2, 2009-01 ,pp. : 105-113

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 67-76

Karger

Access to resources Recommend Favorite